News Chart Monte Rosa Therapeutics, Inc.

Stocks

GLUE

US61225M1027

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-08-21 EDT			5-day change	1st Jan Change
14.30 ^USD	-3.25%		-7.74%	-8.80%

08-06	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M	MT

3e7f5fbe03dd6f8bb.8JIsef3BcUkaxCFpe81Br7IzwLhlJAbD6D89sW-ljsk.iNREO7-eGBp3vlg5OKQOzeJpk94JTlTuuGZS9DDow7--o09Oh5cBDFOCbA~308914a47fc4d081fa542b3cdafbc3eb